Why should I choose PrenatalSafe?

Europe's most comprehensive and most reliable NIPT test panel

Next-Generation CE-IVD Technology + Proprietary CE-IVD NIPT FLOW™ Algorithm

1. Sensitivity and specificity of > 99.9% proven in studies on 71,740 pregnancies.
2. High resolution: coverage of 50 Million reads (test accuracy increases as the number of reads increases)
3. High detection at low levels: high accuracy at low cfDNA amounts (FF: 2%) (possibility of performing the test at an earlier stage)
4. Low no-result rate (<0.1%) (reducing the need for invasive procedures such as amniocentesis)
5. PrenatalSafe® has the lowest false-negative rate in published clinical studies, with a 0% false-negative rate.
6. The PrenatalSafe® test is performed in a laboratory with ISO 17025 and ISO 15189 accreditation, more than 20 years of prenatal diagnosis experience and more than 200,000 genetic tests performed per year.
7. The PrenatalSafe® test is prescribed by thousands of gynaecologists worldwide.
8. The PrenatalSafe® test is the only NIPT to date that screens both genome-wide chromosomal abnormalities and serious genetic diseases in the fetus in a single test.
9. Unlike other commercially available NIPT tests, the PrenatalSafe® test offers a free Rh(D) test (RhSafe). 
10. Free counselling service with a staff of 11 genetic specialists.

1. Analysis for common trisomies was performed on more than 70,000 samples.
2. Sex chromosome aneuploidies were analysed in more than 65,000 samples.
3. Other anomalies were examined in more than 40,000 samples.

*The only test with scientific data on microdeletions

Genetic Science at the Service of Clinical Practice

1. Compliance with the UNI EN ISO 15189:2013 standard (the only accredited laboratory in Italy for NIPT)
2. CE-IVD Certified Technology 
3. Advisory team of 11 Genetic Specialists
4. UN3373 authorization for transporting biological specimens
5. Sample traceability
6. Comprehensive insurance coverage